Learn to manage type 2 diabetes while navigating early-stage Alzheimer's with expert advice on symptoms, simplified routines, and home safety strategies.

Researchers from several partner institutions of the German Center for Diabetes Research (DZD) have collaborated with ...

Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Nearly 1 in 3 US adolescents have prediabetes or type 2 diabetes, with abdominal adiposity being the strongest independent predictor, analysis of national survey data from 2021 to 2023 shows.

NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...

Type 2 diabetes is the most common kind of diabetes. Lifestyle factors such as diet and exercise, genetics, and some medications can cause you to develop the condition. It’s sometimes called ...

A new nationwide analysis shows very early childhood Type 2 diabetes (T2D) is still uncommon but linked with where children ...

A recent study has found that eating higher levels of red meat is associated with an increased risk of developing type 2 ...

An investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, orforglipron (Eli Lilly), demonstrated superior ...

Here’s something big: scientists in China have actually reversed type 2 diabetes using stem-cell therapy. It’s a major step ...

The global type 2 diabetes market size surpassed USD 40.09 billion in 2025 and is projected to reach approximately USD 79.25 ...